These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 8466590

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Urinary excretion of catecholamine metabolites in hyperkinetic child syndrome.
    Khan AU, Dekirmenjian H.
    Am J Psychiatry; 1981 Jan; 138(1):108-10. PubMed ID: 7446760
    [No Abstract] [Full Text] [Related]

  • 4. Stimulants, urinary catecholamines, and indoleamines in hyperactivity. A comparison of methylphenidate and dextroamphetamine.
    Zametkin AJ, Karoum F, Linnoila M, Rapoport JL, Brown GL, Chuang LW, Wyatt RJ.
    Arch Gen Psychiatry; 1985 Mar; 42(3):251-5. PubMed ID: 2579615
    [Abstract] [Full Text] [Related]

  • 5. Urinary catecholamines in attention-deficit hyperactivity disorder with and without comorbid anxiety.
    Pliszka SR, Maas JW, Javors MA, Rogeness GA, Baker J.
    J Am Acad Child Adolesc Psychiatry; 1994 Oct; 33(8):1165-73. PubMed ID: 7982867
    [Abstract] [Full Text] [Related]

  • 6. The effect of methylphenidate on urinary catecholamine excretion in hyperactivity: a partial replication.
    Zametkin AJ, Hamburger SD.
    Biol Psychiatry; 1988 Feb 15; 23(4):350-6. PubMed ID: 3342265
    [Abstract] [Full Text] [Related]

  • 7. Urinary MHPG and HVA excretion in boys with attention deficit disorder and hyperactivity treated with d-amphetamine.
    Shekim WO, Javaid J, Davis JM, Bylund DB.
    Biol Psychiatry; 1983 Jun 15; 18(6):707-14. PubMed ID: 6871304
    [Abstract] [Full Text] [Related]

  • 8. Urinary MHPG excretion in minimal brain dysfunction and its modification by d-amphetamine.
    Shekim WO, Dekirmenjian H, Chapel JL.
    Am J Psychiatry; 1979 May 15; 136(5):667-71. PubMed ID: 434244
    [Abstract] [Full Text] [Related]

  • 9. [Neurochemical and neurotransmitter studies in patients with learning disabilities].
    Matsuishi T, Yamashita Y.
    No To Hattatsu; 1999 May 15; 31(3):245-8. PubMed ID: 10355264
    [Abstract] [Full Text] [Related]

  • 10. Norepinephrine and dopamine metabolites and educational variables in boys with attention deficit disorder and hyperactivity.
    Shekim WO, Sinclair E, Glaser R, Horwitz E, Javaid J, Bylund DB.
    J Child Neurol; 1987 Jan 15; 2(1):50-6. PubMed ID: 3624828
    [Abstract] [Full Text] [Related]

  • 11. Norepinephrine metabolism and clinical response to dextroamphetamine in hyperactive boys.
    Shekim WO, Dekirmenjian H, Chapel JL, Javaid J, Davis JM.
    J Pediatr; 1979 Sep 15; 95(3):389-94. PubMed ID: 469661
    [Abstract] [Full Text] [Related]

  • 12. Effects of d-amphetamine on urinary metabolites of dopamine and norepinephrine in hyperactive boys.
    Shekim WO, Javaid J, Dekirmenjian H, Chapel JL, Davis JM.
    Am J Psychiatry; 1982 Apr 15; 139(4):485-8. PubMed ID: 7065295
    [Abstract] [Full Text] [Related]

  • 13. Biological and psychological aspects of a case of Gilles de la Tourette's syndrome.
    Yeragani VK, Blackman M, Baker GB.
    J Clin Psychiatry; 1983 Jan 15; 44(1):27-9. PubMed ID: 6571833
    [Abstract] [Full Text] [Related]

  • 14. High intercorrelations among urinary outputs of norepinephrine and its major metabolites. A replication in depressed patients and controls.
    Roy A, Guthrie S, Karoum F, Pickar D, Linnoila M.
    Arch Gen Psychiatry; 1988 Feb 15; 45(2):158-61. PubMed ID: 3337613
    [Abstract] [Full Text] [Related]

  • 15. Urinary 3-methoxy-4-hydroxyphenylglycol sulfate excretion in seventy-three schoolchildren with minimal brain dysfunction syndrome.
    Shen YC, Wang YF.
    Biol Psychiatry; 1984 Jun 15; 19(6):861-70. PubMed ID: 6743722
    [Abstract] [Full Text] [Related]

  • 16. Urinary catecholamine metabolites in hyperkinetic boys treated with d-amphetamine.
    Shekim WO, Dekirmenjian H, Chapel JL.
    Am J Psychiatry; 1977 Nov 15; 134(11):1276-9. PubMed ID: 910984
    [Abstract] [Full Text] [Related]

  • 17. Catecholamine metabolism during heroin use.
    Schildkraut JJ, Meyer RE, Orsulak PJ, Mirin SM, Roffman M, Platz PA, Grab E, Randall ME, McDougle M.
    Am J Psychiatry; 1977 May 15; 134(5):534-7. PubMed ID: 848581
    [Abstract] [Full Text] [Related]

  • 18. Day-to-day intraindividual reliability and interindividual differences in monoamines excretion.
    Curtin F, Walker JP, Schulz P.
    J Affect Disord; 1996 Jun 05; 38(2-3):173-8. PubMed ID: 8791186
    [Abstract] [Full Text] [Related]

  • 19. High correlation of norepinephrine and its major metabolite excretion rates.
    Linnoila M, Karoum F, Potter WZ.
    Arch Gen Psychiatry; 1982 May 05; 39(5):521-3. PubMed ID: 7092485
    [Abstract] [Full Text] [Related]

  • 20. Toward a biochemical classification of depressive disorders. I. Differences in urinary excretion of MHPG and other catecholamine metabolites in clinically defined subtypes of depressions.
    Schildkraut JJ, Orsulak PJ, Schatzberg AF, Gudeman JE, Cole JO, Rohde WA, LaBrie RA.
    Arch Gen Psychiatry; 1978 Dec 05; 35(12):1427-33. PubMed ID: 727878
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.